POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE III

POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE III was reported 29 times

POLYGLANDULAR AUTOIMMUNE SYNDROME TYPE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NELFINAVIR MESYLATE 2 0.0010
1 INSULIN DEGLUDEC AND LIRAGLUTIDE 1 0.0006
2 LOPINAVIR AND RITONAVIR 5 0.0004
3 CAPTOPRIL 3 0.0003
4 ALISKIREN HEMIFUMARATE 1 0.0002
5 AMPICILLIN INJECTION 1 0.0001
6 TRETINOIN 1 0.0001
7 AMPICILLIN 1 0.0001
8 MINOCYCLINE 1 0.0001
9 LAMIVUDINE 2 0.0001
10 ERYTHROPOIETIN 1 0.0000
11 HUMAN IMMUNOGLOBULIN G 1 0.0000
12 ATOMOXETINE HYDROCHLORIDE 1 0.0000
13 PREDNISOLONE ORAL SOLUTION 5 0.0000
14 FILGRASTIM 1 0.0000
15 BOSENTAN 1 0.0000
16 FERROUS SULFATE 1 0.0000
17 METFORMIN HYDROCHLORIDE TABLETS 1 0.0000
18 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 1 0.0000
19 METFORMIN HYDROCHLORIDE TABLET 1 0.0000
20 METFORMIN HYDROCHLORIDE 1 0.0000
21 METFORMIN ER 500 MG 5 0.0000
22 DOXYCYCLINE HYCLATE 1 0.0000
23 DOXYCYCLINE 1 0.0000
24 SECUKINUMAB 2 0.0000
25 NIVOLUMAB 1 0.0000
26 BUPROPION HYDROCHLORIDE 1 0.0000
27 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
28 USTEKINUMAB 1 0.0000
29 SERTRALINE HYDROCHLORIDE 1 0.0000
30 ARIPIPRAZOLE 1 0.0000
31 SILDENAFIL CITRATE 1 0.0000
32 CLONAZEPAM 1 0.0000
33 FOLIC ACID 1 0.0000
34 LEVOTHYROXINE SODIUM 1 0.0000
35 LISINOPRIL 1 0.0000
36 PREDNISONE 1 0.0000